Overview

An absorbable heart stent—commonly known as a Bioresorbable Vascular Scaffold (Bvs) Market is a temporary vascular support device designed to restore blood flow in blocked coronary arteries. Unlike traditional metallic drug-eluting stents (DES) that remain permanently in the vessel wall, absorbable heart stents dissolve into non-toxic biocomponents (such as water and carbon dioxide) over a period of 2 to 3 years.

 Once the scaffold fully resorbs, it allows the artery to regain its natural flexibility and vasomotor function, reducing long-term risks such as late-stage thrombosis.

Get a Sample Report of Bioresorbable Vascular Scaffold (Bvs) Market  Forecast @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-absorbable-heart-stent-market

Market Size and Forecast (2026–2033)

The global absorbable heart stent market is experiencing strong growth, propelled by the rising incidence of coronary artery disease (CAD), advancements in biomaterials, and an increasing preference for minimally invasive interventions.

2025 Valuation: USD 487.98 million

2033 Projection: USD 1,071.40 million

Forecast Period: 2026 to 2033

Compound Annual Growth Rate (CAGR): 10.33% 

Market Segmentation

1. By Material Type

Polymer-Based Scaffolds: Dominates the market (held ~46.3% share in 2025). Primarily composed of Poly-L-Lactic Acid (PLLA), offering biocompatibility and controlled degradation.

Metal-Based Scaffolds: Forecasted as the fastest-growing segment at a 10.5% CAGR through 2033. Utilizes biodegradable metallic alloys such as magnesium and iron-based scaffolds, which offer higher radial strength and thinner strut profiles.

2. By Application

Coronary Artery Disease (CAD): Holds the majority market share due to high global disease prevalence and volume of percutaneous coronary interventions (PCI).

Peripheral Artery Disease (PAD): Expanding application area for resorbable scaffold technology in lower extremity vessels.

3. By End-User

Hospitals & Cardiac Centers: Leading end-user segment due to specialized cardiac cath lab infrastructure and volume of complex interventional procedures.

Ambulatory Surgical Centers (ASCs) & Clinics: Growing rapidly driven by same-day discharge protocols and outpatient PCI expansion.

Geographic Share

North America: Commands the largest revenue share, driven by high CAD prevalence, mature healthcare infrastructure, and rapid adoption of novel cardiac technologies.

Asia-Pacific: Anticipated to be the fastest-growing region during the 2026–2033 period. Growth is fueled by large patient populations in China and India, expanding cath lab availability, and growing medical tourism.

Europe: Maintains a solid share, supported by favourable clinical trial networks and adoption of next-generation bioresorbable polymers.

Key Players

Major medtech manufacturers and specialized biomaterial innovators leading the market include:

Abbott Laboratories (Developer of early and next-generation bioresorbable platforms)

Biotronik SE & Co. KG (Pioneer in bioresorbable magnesium scaffold technology)

Boston Scientific Corporation 

Terumo Corporation 

MicroPort Scientific Corporation 

REVA Medical, Inc.

Elixir Medical Corporation

LSI Keyword (Latent Semantic Indexing)

Market Outlook (2026–2033)

The outlook for absorbable heart stents is highly positive as materials science resolves earlier challenges regarding scaffold thickness and radial strength. Next-generation devices feature ultra-thin struts, optimized drug-eluting coatings (such as sirolimus), and predictable resorption profiles. The shift toward temporary vessel scaffolding allows for future treatment options on the same artery segment (e.g., bypass surgery or re-stenting), positioning bioresorbable technology as a central component of future interventional cardiology.

Frequently Asked Questions (FAQ)

What is the primary advantage of an absorbable heart stent over a traditional stent?

A traditional metallic stent remains permanently in the artery, which can cause chronic inflammation or limit future vessel motion. An absorbable heart stent provides temporary support and then fully dissolves, leaving behind a naturally healed artery capable of normal dilation.

How long does it take for an absorbable heart stent to dissolve?

Most bioresorbable vascular scaffolds (BVS) are engineered to maintain radial strength for 3 to 6 months during healing, followed by complete bioresorption over 2 to 3 years.

About Us:

Data Bridge is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Browse More Reports:

 Global Infectious Disease Drug Market
 Global Agro Textile Market
 Global Compostable Multilayer Films Market
 Global Plastic Bags & Sacks Market
 Global Digital Dose Inhaler Market

Contact :                                                                                    

Data Bridge Market Research Private Ltd .

3665 Kingsway - Suite 300 Vancouver BC V5R 5W2 Canada

+1 614 591 3140 (US)